Ken Walsh

Ken Walsh is a seasoned professional in market access and commercialization within the life sciences sector, currently serving as Partner - Access & Commercialization at Clarivate since February 2022. Prior roles include Senior Vice President & Global Head of Market Access at Lifescience Dynamics Limited, Principal & Head of Global Market Access at TRINITY, and Director of Life Science Strategy at Guidehouse. Notable experience also consists of leading Emerging Markets Pricing at GSK and Global Pricing and Market Access for biopharmaceuticals at Sandoz. Ken Walsh has a strong background in consulting, having held significant positions at Bridgehead International and Kantar Health, alongside earlier roles at GfK HealthCare Asia and Cambridge Pharma Consultancy. Ken Walsh holds an MSc in Finance from Bayes Business School and a MA (hons) in Economics from Heriot-Watt University.